Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs.
about
Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and managementCurrent concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.Obesity and headache: part I--a systematic review of the epidemiology of obesity and headache.Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension.Cerebral venous sinus stenting for pseudotumor cerebri: A review.Update on idiopathic intracranial hypertensionIdiopathic intracranial hypertension: relation between obesity and visual outcomes.Update on the pathophysiology and management of idiopathic intracranial hypertension.Noninvasive intracranial hypertension detection utilizing semisupervised learning.Epidemiology and risk factors for idiopathic intracranial hypertension.Cognitive function in idiopathic intracranial hypertension: a prospective case-control studyHigh-pressure headaches: idiopathic intracranial hypertension and its mimics.Fifteen-minute consultation: the child with idiopathic intracranial hypertension.Idiopathic intracranial hypertension occurred after spinal surgery: report of two rare cases and systematic review of the literature.Research Registries: A Tool to Advance Understanding of Rare Neuro-Ophthalmic Diseases.Population-based incidence and clinical characteristics of idiopathic intracranial hypertension.Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension.Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting.The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey.Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH).Idiopathic intracranial hypertension is not benign: a long-term outcome study.
P2860
Q26765034-63D73CB8-EADE-42C3-BD4A-CC5A866F9555Q30238677-58ACE96B-7F06-49F0-BB2E-14A426F210C5Q34403389-A5AF4E19-6835-4156-B464-8C042E061394Q34779953-2DE8FB78-BFEC-4DA8-B2CD-A845843A0217Q35040617-48A96B58-16AE-41BF-94DF-2A39BFD9F3CAQ35126814-83EAE30E-26BB-46DF-BB42-4160CE767604Q35881587-6AB72A3A-BCEC-4700-A7C7-E9401E658DB9Q36529652-E8C820FE-CBD7-4910-8931-B5B745C64587Q36721524-C9EDB4D3-3FEE-4B9D-856F-527F04068F05Q37395260-4169F0C9-6523-48A1-B76E-AD3C4C2ED1CFQ37704487-48EAEA47-50AF-48E7-8CF0-DF47E7263DCEQ38061011-273B43A5-DD38-49B7-87E3-553EDD3A16A4Q38199342-7BD9D869-A868-4315-87E5-856C0F5C7C75Q38836418-FD311D1C-5DEC-4CE2-BE73-9ACBE245EC31Q38844159-70BBED81-3323-4496-B492-C2B86F4A1924Q39154137-89908358-5887-447D-AF20-7ED0C8AD08CDQ40340326-B838BBE7-9F26-4FED-941F-5B022A7EA3CEQ41947767-17EEE9C6-3EAC-47B5-995D-43E0A9EA77CFQ42584276-1FF6E8B4-350B-4D2E-911E-7621B39F292FQ45155090-AAF92A0A-82CD-404A-AEC9-3D48F594ABE9Q45173346-669C788D-724A-48C0-B1FF-E8637373C39CQ51149164-8DD6D4CD-4326-4F97-B130-4DB64183AE08Q53109834-659EF731-F350-4471-97A3-312360F4C71BQ53196140-B676D31C-F453-41CE-BBC3-CDBA6A5C36E3
P2860
Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@en
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@nl
type
label
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@en
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@nl
prefLabel
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@en
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@nl
P2093
P2860
P1433
P1476
Idiopathic intracranial hypert ...... evalence and healthcare costs.
@en
P2093
P2860
P304
P356
10.1111/J.1467-789X.2010.00799.X
P577
2010-08-26T00:00:00Z